Hepner Adrian
Insider CIK 1637347 · COYA Chief Medical Officer · EGRX Executive VP
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| COYA Coya Therapeutics, Inc. | A Award deriv | 2023-02-27 | 2023-03-01 | 115,000 | — | $0 | 115,000 | SEC↗ |
| COYA Coya Therapeutics, Inc. | P Buy deriv | 2023-01-03 | 2023-01-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| COYA Coya Therapeutics, Inc. | P Buy | 2023-01-03 | 2023-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2020-01-23 | 2020-01-27 | 1,630 | $57.98 | $94.5K | 48,784 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2020-01-07 | 2020-01-07 | 815 | $57.38 | $46.8K | 50,414 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2020-01-05 | 2020-01-07 | 55,000 | — | $0 | 55,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award | 2020-01-05 | 2020-01-07 | 24,000 | — | $0 | 51,229 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2019-01-23 | 2019-01-25 | 42,500 | — | $0 | 42,500 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award | 2019-01-23 | 2019-01-25 | 19,000 | — | $0 | 27,229 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2019-01-07 | 2019-01-25 | 771 | $41.33 | $31.9K | 8,229 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2018-01-07 | 2018-01-09 | 27,000 | — | $0 | 27,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2018-01-07 | 2018-01-09 | 43,000 | — | $0 | 43,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award | 2018-01-07 | 2018-01-09 | 9,000 | — | $0 | 9,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2017-01-04 | 2017-01-06 | 67,200 | — | $0 | 67,200 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2016-01-04 | 2016-01-05 | 62,100 | — | $0 | 62,100 | SEC↗ |